Interferoning with Plasmodium development in the liver

Justin A Boddey1, Friedrich Frischknecht2

  • 1Division of Infection and Global Health, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Melbourne, VIC 3010, Australia.

Cell Host & Microbe
|April 10, 2025
PubMed

Insights

Type I interferons limit Plasmodium liver infection by triggering lysosome fusion and membrane disruption. These newly discovered pathways lead to the clearance of malaria parasites during their liver stage.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Type I interferons (IFN-I) are known to restrict Plasmodium liver-stage infections.
  • The precise molecular mechanisms by which IFN-I limits Plasmodium parasites in the liver remain largely unknown.

Purpose of the Study:

  • To elucidate the IFN-I-mediated mechanisms responsible for controlling Plasmodium liver-stage infections.
  • To identify host cell pathways activated by IFN-I that target the parasite.

Main Methods:

  • Utilized in vitro models of Plasmodium liver-stage infection.
  • Employed advanced microscopy and cell biology techniques to visualize host-parasite interactions.
  • Investigated the role of lysosomes and membrane dynamics in parasite clearance.

Main Results:

  • Identified two distinct IFN-I-induced pathways crucial for parasite restriction.
  • Demonstrated that IFN-I signaling promotes the fusion of host cell lysosomes with the parasitophorous vacuole membrane.
  • Showed that these pathways lead to the disruption of parasite membranes and subsequent clearance.

Conclusions:

  • IFN-I employs dual mechanisms involving lysosomal fusion and membrane disruption to eliminate Plasmodium parasites during liver infection.
  • These findings reveal novel host-directed strategies for controlling malaria transmission and infection.